Clostridium difficile ribotype 023 lacks the ability to hydrolyze esculin, leading to false-negative results on chromogenic agar

Journal of Clinical Microbiology

Volumn 54, Issue 5, 2016, Pages 1404-1405

  Connor, Mairéad C ^a   Fairley, Derek J ^b   McKenna, James P ^b   Marks, Nikki J ^a   McGrath, John W ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; BETA GLUCOSIDASE; ESCULIN;

BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLOSTRIDIUM DIFFICILE RIBOTYPE 023; FALSE NEGATIVE RESULT; GENOTYPE; HYDROLYSIS; LETTER; MICROBIAL MORPHOLOGY; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT; CHEMISTRY; CLASSIFICATION; CLOSTRIDIUM INFECTION; CULTURE MEDIUM; DIAGNOSTIC TEST; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROCEDURES; RIBOTYPING;

BACTERIOLOGICAL TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CULTURE MEDIA; DIAGNOSTIC TESTS, ROUTINE; ESCULIN; HUMANS; HYDROLYSIS; RIBOTYPING;

EID: 84964938444     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00234-16     Document Type: Letter

References (15)

1. Bartlett JG. 2006. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 145:758-764. http: //dx.doi.org/10.7326/0003-4819-145-10-200611210-00008.
2. James AL, Perry JD, Ford M, Armstrong L, Gould FK. 1997. Cyclohex-enoesculetin-beta-D-glucoside: a new substrate for the detection of bacterial beta-D-glucosidase. J Appl Microbiol 82:532-536. http://dx.doi.org /10.1046/j.1365-2672.1997.00370.x.
3. MacFaddin JF. 1981. Biochemical tests for identification of medical bacteria, 2nd ed. Williams & Wilkins, Philadelphia, PA.
4. Lozniewski A, Rabaud C, Dotto E, Weber M, Mory F. 2001. Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of premier cytoclone A-B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains. J Clin Microbiol 39:1996-1998. http://dx.doi.org/10.1128/JCM.39.5.1996-1998.2001.
5. Qadri SM, Johnson S, Smith JC, Zubairi S, Gillum RL. 1981. Comparison of spot esculin hydrolysis with the PathoTec strip test for rapid differentiation of anaerobic bacteria. J Clin Microbiol 13:459-462.
6. Sultana Q, Chaudhry NA, Munir M, Anwar MS, Tayyab M. 2000. Diagnosis of Clostridium difficile antibiotic associated diarrhoea culture versus toxin assay. J Pak Med Assoc 50:246-249.
7. Verlasovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (ed). 2011. Manual of clinical microbiology, 10th ed. American Society for Microbiology Press, Washington, DC.
8. Dingle KE, Griffiths D, Didelot X, Evans J, Vaughan A, Kachrimanidou M, Stoesser N, Jolley KA, Golubchik T, Harding RM, Peto TE, Fawley W, Walker AS, Wilcox M, Crook DW. 2011. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One 6:e19993. http://dx .doi.org/10.1371/journal.pone.0019993.
9. Edberg SC, Bell SR. 1985. Lack of constitutive beta-glucosidase (esculinase) in the genus Fusobacterium. J Clin Microbiol 22:435-437.
10. Eckert C, Burghoffer B, Lalande V, Barbut F. 2013. Evaluation of the chromogenic agar chromID C. difficile. J Clin Microbiol 51:1002-1004. http://dx.doi.org/10.1128/JCM.02601-12.
11. Cellier M, Halimi D, Orenga S. May 2013. Use of a beta-glucosidase activator for the detection and/or identification of C. difficile. US patent 20130137126 A1.
12. Fairley DJ, McKenna JP, Stevenson M, Weaver J, Gilliland C, Watt A, Coyle PV. 2015. Association of Clostridium difficile ribotype 078 with detectable toxin in human stool specimens. J Med Microbiol 64:1341-1345. http://dx.doi.org/10.1099/jmm.0.000165.
13. van den Berg RJ, Schaap I, Templeton KE, Klaassen CHW, Kuijper EJ. 2007. Typing and subtyping of Clostridium difficile isolates by using multiple- locus variable-number tandem-repeat analysis. J Clin Microbiol 45: 1024-1028. http://dx.doi.org/10.1128/JCM.02023-06.
14. Curry SR, Muto CA, Schlackman JL, Pasculle AW, Shutt KA, Marsh JW, Harrison LH. 2013. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 57:1094-1102. http: //dx.doi.org/10.1093/cid/cit475.
15. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, Cairns M, Curran MD, Dodgson KJ, Green SM, Hardy KJ, Hawkey PM, Magee JG, Sails AD, Wren MWD. 2012. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping- based surveillance scheme in England. Clin Infect Dis 55:1056-1063. http://dx.doi.org/10.1093/cid/cis614.